title: Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study.
abstract: OBJECTIVE
  To introduce new terminology and validate its reliability for the analysis of optical coherence tomography (OCT) scans, compare clinical detection of cystoid macular oedema (CMO) and subretinal fluid (SRF) with OCT findings, and to study the effect of photodynamic therapy (PDT) on the foveal morphology.
  
  
  METHODS
  Patients with subfoveal, predominantly classic choroidal neovascularisation (CNV) secondary to age related macular degeneration (AMD) undergoing PDT were evaluated with refraction protocol best corrected logMAR visual acuity (VA), slit lamp biomicroscopy, stereoscopic fluorescein angiography (FFA), and OCT. New terminologies introduced to interpret the OCT scans were: neuroretinal foveal thickness (NFT), bilaminar foveal thickness (BFT), outer high reflectivity band thickness (OHRBT), intraretinal fluid (IRF), subretinal fluid (oSRF), and vitreomacular hyaloid attachment (VMHA).
  
  
  RESULTS
  Fifty six eyes of 53 patients were studied. VA was better in eyes with a thinner outer high reflectivity band (OHRBT) (p = 0.02) and BFT (p = 0.05). BFT was less in eyes that had undergone a greater number of PDT treatments (p = 0.04). There was poor agreement between OCT and clinical examination in the detection of CMO and subretinal fluid (kappa = 0.289 and kappa = 0.165 respectively). To validate the interpretation and measurements on OCT, two groups of 20 scans were analysed by two independent observers. There was good agreement between the observers in the detection of IRF, oSRF, and VMHA (p<0.001). Measurements of NFT and BFT had a high reproducibility, and of OHRBT reproducibility was low.
  
  
  CONCLUSIONS
  New terminology has been introduced and tested. OCT appears to be superior to clinical examination and FFA in the detection of CMO. In this study, better vision was associated with a thinner OHRBT and/or the absence of SRF giving insight into the biological effect of PDT.
authors.affiliation: St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool L7 8XP, UK. jayashree2001@hotmail.com
authors.forename: J
authors.initials: J
authors.lastname: Sahni
authors.forename: P
authors.initials: P
authors.lastname: Stanga
authors.forename: D
authors.initials: D
authors.lastname: Wong
authors.forename: S
authors.initials: S
authors.lastname: Harding
mesh_terms: D000368:Aged; D016510:Corneal Neovascularization / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D010778:Photochemotherapy; D011446:Prospective Studies; D012160:Retina / Q000473:pathology*; D009626:Terminology as Topic; D041623:Tomography, Optical Coherence
references.citation: Arch Ophthalmol. 2001 Feb;119(2):198-207
references.pmid: 11176980
references.citation: Arch Ophthalmol. 1995 Mar;113(3):325-32
references.pmid: 7887846
references.citation: Ophthalmology. 1996 Aug;103(8):1260-70
references.pmid: 8764797
references.citation: Arch Ophthalmol. 1997 Nov;115(11):1425-8
references.pmid: 9366674
references.citation: Am J Ophthalmol. 1999 Jun;127(6):688-93
references.pmid: 10372879
references.citation: Jpn J Ophthalmol. 2001 May-Jun;45(3):252-8
references.pmid: 11369374
references.citation: Eye (Lond). 2001 Jun;15(Pt 3):407-12
references.pmid: 11450766
references.citation: Retina. 2001;21(5):478-86
references.pmid: 11642377
references.citation: Arch Ophthalmol. 2002 Jun;120(6):731-7
references.pmid: 12049577
references.citation: Graefes Arch Clin Exp Ophthalmol. 2002 Sep;240(9):748-57
references.pmid: 12271373
references.citation: Am J Ophthalmol. 2002 Oct;134(4):566-76
references.pmid: 12383814
references.citation: Arch Ophthalmol. 1995 Aug;113(8):1019-29
references.pmid: 7639652
references.citation: Ophthalmology. 1995 Feb;102(2):217-29
references.pmid: 7862410
references.citation: Arch Ophthalmol. 1999 Oct;117(10):1329-45
references.pmid: 10532441
references.citation: Retina. 2000;20(2):115-20
references.pmid: 10783942
references.citation: Doc Ophthalmol. 1999;97(3-4):361-6
references.pmid: 10896351
references.citation: Graefes Arch Clin Exp Ophthalmol. 2003 Oct;241(10):797-802
references.pmid: 14605900
references.citation: Ophthalmology. 2004 Apr;111(4):712-5
references.pmid: 15051203
references.citation: Surv Ophthalmol. 1988 May-Jun;32(6):375-413
references.pmid: 2457955
references.citation: Arch Ophthalmol. 1991 Feb;109(2):211-5
references.pmid: 1704212
references.citation: Arch Ophthalmol. 1991 Aug;109(8):1115-9
references.pmid: 1867554
references.citation: Ophthalmology. 1992 Jun;99(6):933-43
references.pmid: 1630784
references.citation: Ophthalmology. 1993 Oct;100(10):1519-35
references.pmid: 7692366
references.citation: Ophthalmology. 1995 Feb;102(2):205-10
references.pmid: 7862408